Condition: Diabetic Peripheral Neuropathy

Evaluation of the efficacy of a low and high dose of LX9211 compared to placebo in reducing pain related to diabetic peripheral neuropathy over an 11 week assessment period.

Location(s): Jacksonville- LaVilla (Downtown), Lake CIty, Macon

Condition: Diabetic Peripheral Neuropathy